Russell Investments Group’s Biomerica BMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-28,179
Closed -$73.9K 3705
2024
Q3
$73.9K Sell
28,179
-86
-0.3% -$246 ﹤0.01% 2711
2024
Q2
$99.4K Buy
28,265
+86
+0.3% +$438 ﹤0.01% 2629
2024
Q1
$188K Buy
28,179
+2,984
+12% +$24.2K ﹤0.01% 2454
2023
Q4
$252K Buy
25,195
+3,286
+15% +$24.9K ﹤0.01% 2386
2023
Q3
$150K Sell
21,909
-802
-4% -$7.95K ﹤0.01% 2541
2023
Q2
$247K Buy
22,711
+927
+4% +$11K ﹤0.01% 2426
2023
Q1
$326K Buy
21,784
+13,813
+173% +$298K ﹤0.01% 2380
2022
Q4
$214K Buy
7,971
+4,008
+101% +$115K ﹤0.01% 2555
2022
Q3
$124K Buy
+3,963
New +$103K ﹤0.01% 2633
2021
Q2
Sell
-35,669
Closed -$1.56M 3209
2021
Q1
$1.56M Sell
35,669
-13,506
-27% -$692K ﹤0.01% 2014
2020
Q4
$1.96M Buy
49,175
+37,097
+307% +$1.86M ﹤0.01% 1772
2020
Q3
$669K Buy
+12,078
New +$781K ﹤0.01% 2258

Other funds holding BMRA

Russell Investments Group's BMRA Position: Q4 2024 in Review

Russell Investments Group sold out of Biomerica (BMRA) in Q4 2024, closing a stake of 28,179 shares — an estimated $73.9K sold.

Russell Investments Group first reported a position in BMRA in Q3 2020 and held it in 12 quarters. The position peaked at $1.96M in Q4 2020. 21 funds tracked by Wall St. Rank hold BMRA as of Q4 2024.

  • Russell Investments Group reported no remaining Biomerica position as of Q4 2024 after selling out during the quarter.
  • Russell Investments Group sold 28,179 Biomerica shares in Q4 2024, an estimated $73.9K.
  • Russell Investments Group first reported a position in Biomerica in Q3 2020 and held it in 12 quarters.
  • Russell Investments Group's Biomerica position peaked at $1.96M in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Biomerica as of Q4 2024.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.